Consideration of host-viral interactions in the pathogenesis of Kaposi's sarcoma

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 4 SUPPL., 1999, Pages

  Offermann, Margaret K ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Antiviral responses; Double stranded RNA; Endothelial cells; Human herpesvirus type 8; Kaposi's sarcoma

Indexed keywords

B LYMPHOCYTE; CARCINOGENESIS; CONFERENCE PAPER; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS RESISTANCE;

ANIMALS; ENDOTHELIUM; HERPESVIRUS 8, HUMAN; HUMANS; MODELS, BIOLOGICAL; PROTEIN KINASES; RNA, MESSENGER; SARCOMA, KAPOSI; VASCULAR CELL ADHESION MOLECULE-1;

HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8; PAPOVAVIRIDAE;

EID: 0033179064     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (69)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
2. Chang Y, Ziegler J, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med 1996;156:202-4.
3. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995;345:1043-4.
4. Dupin N, Grandadam M, Calvez V, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995;345:761-2.
5. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995;332:1181-5.
6. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996;2:342-6.
7. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332: 1186-91.
8. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995;86:2708-14.
9. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castle-man's disease. Blood 1995;86:1276-80.
10. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996;335:233-41.
11. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996;2:925-8.
12. Blackbourn DJ, Ambroziak J, Lennette E, Adams M, Ramachandran B, Levy JA. Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 1997;349:609-11.
13. Chatlynne LG, Lapps W, Handy M, et al., Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 1998;92:53-8.
14. Jones RR. The histogenesis of Kaposi's sarcoma. Am J Dermatol 1986;8:369-70.
15. Foreman KE, Bacon PE, Hsi ED, Nickoloff BJ. In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma. J Clin Invest 1997;99: 2971-8.
16. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995;1:1274-8.
17. Li JJ, Huang YQ, Cockerell CJ, Friedman-Kien AE. Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization. Am J Pathol 1996;148:1741-8.
18. Staskus KA, Zhong W, Gebhard K, et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997;71:715-9.
19. Corbeil J, Evans LA, Vasak E, Cooper DA, Penny R. Culture and properties of cells derived from Kaposi sarcoma. J Immunol 1991; 146:2972-6.
20. Salahuddin SZ, Nakamura S, Biberfeld P, et al. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 1988;242:430-3.
21. Yang J, Xu Y, Zhu C, Hagan K, Lawley T, Offermann MK. Regulation of adhesion molecule expression in Kaposi's sarcoma cells. J Immunol 1994;152:361-73.
22. Blasig C, Zietz C, Haar B, et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 1997;71:7963-8.
23. Humphrey RW, O'Brien TR, Newcomb FM, et al. Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs. Blood 1996;88:297-301.
24. Kikuta H, Itakura O, Taneichi K, Kohno M. Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castleman's disease. Br J Haematol 1997;99:790-3.
25. Bigoni B, Dolcetti R, de Lellis L, et al. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis 1996;173:542-9.
26. Imhof BA, Dunon D. Leukocyte migration and adhesion. Adv Immunol 1995;58:345-415
27. Huang YQ, Friedman KA, Li JJ, Nickoloff BJ. Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD 14, and VCAM-1, but not factor VIII or ELAM-1. Arch Dermatol 1993;129:1291-6.
28. Collins T, Read M, Neish AS, Whitley Z, Thanos D, Maniatis T. Transcriptional regualtion of endotehlail eel adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995;9:899-909.
29. Marui N, Offermann MK, Swerlick R, et al. Vascular cell adhesion molecule-1 (VCAM-1 ) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. Mol Cell Biol 1993;13:6283-9.
30. Offermann M, Zimring J, Melits K, et al. Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule-1 by poly (I). poly (C) in endothelial cells. Eur J Biochem 1995;232:28-36.
31. Hovanessian AG. Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2′,5′-oligoadenylate synthetases. J Interferon Res 1991;11:199-205.
32. Chang CH, Hammer J, Loh JE, Fodor WL, Flavell RA. The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-I). Immunogenetics 1992;35:378-84.
33. Gao S-J, Boschoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 1997;16:1979-85.
34. Zimring JC, Goodbourn S, Offermann MK. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 1998;72:701-7.
35. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274:1739-44.
36. Harada H, Takahashi E, Itoh S, Harada K, Hori TA, Taniguchi T. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol 1994;14:1500-9.
37. Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the Interferon system. Mol Cell Biol 1993;13:4531-8.
38. Harada H, Kitagawa M, Tanaka N, et al. Anti-oncogenic and oncogenic potentials of Interferon regulatory factors-1 and -1. Science 1993;259:971-4.
39. Reis LF, Harada H, Wolchok JD, Taniguchi T, Vilcek J. Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO J 1992;1:185-93.
40. Taniguchi T, Harada H, Lamphier M. Regulation of the Interferon system and cell growth by the IRF transcription factors. J Cancer Res Clin Oncol 1995;121:516-20.
41. Li M, Lee H, Guo J, et al. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol 1998;72:5433-40.
42. Jacobs BL, Langland JO. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 1996;219:339-49.
43. Smolinski PA, Offermann MK, Eckman JR, Wick TM. Double-stranded RNA induces sickle erythrocyte adherence to endothelium: a potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemia. Blood 1995;85:2945-50.
44. Yang J, Hagan MK, Offermann MK. Induction of IL-6 gene expression in Kaposi's sarcoma cells. J Immunol 1994;152:943-55.
45. Harcourt BH, Rota PA, Hummel KB, Bellini WJ, Offermann MK. Induction of Intercellular adhesion molecule 1 gene expression by measles virus in human umbilical vein endothelial cells. J Med Virol 1999;57:9-16.
46. Butcher E. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1992;67:1033-6.
47. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
48. Akira S, Taga T, Kishimoto T. Interleukin 6 in biology and medicine. Adv Immunol 1993;54:1-78.
49. Pamer E, Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 1998;16:323-58.
50. Hershey JWB. Introduction to translational initiation factors and their regulation by phosphorylation. Semin Virol 1993;4:201-8.
51. Offermann MK, Lin JC, Mar EC, Shaw R, Yang J, Medford RM. Antioxidant-sensitive regulation of inflammatory-response genes in Kaposi's sarcoma cells. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:1-11.
52. Katze M. Games viruses play: a strategic initiative against PKR. Semin Virol 1993;4:259-68.
53. Katze MG. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol 1995;3:75-8.
54. Mathews MB. Viral evasion of cellular defense mechanisms: regulation of PKR by RNA effectors. Semin Virol 1993;268:247-57.
55. Chang HW, Watson JC, Jacobs BL. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 1992;89:4825-9.
56. Davies MV, Elroy SO, Jagus R, Moss B, Kaufman RJ. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol 1992;66:1943-50.
57. Carroll K, Elroy-Stein O, Moss B, Jagus R. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. J Biol Chem 1993;268:12837-42.
58. Katze MG, DeCorato D, Safer B, Galabru J, Hovanessian AG. Adenovirus VAIRNA complexes with the 68 000 Mr protein kinase to regulate its autophosphorylation and activity. Embo J 1987; 6:689-97.
59. Clarke PA, Sharp NA, Clemens MJ. Translational control by the Epstein-Barr virus small RNA EBER-1. Reversal of the double-stranded RNA-induced inhibition of protein synthesis in reticulocyte lysates. Eur J Biochem 1990;193:635-41.
60. Clarke PA, Schwemmle M, Schickinger J, Hilse K, Clemens MJ. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res 1991;19:243-8.
61. Black TL, Safer B, Hovanessian A, Katze MG. The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J Virol 1989;63:2244-51.
62. Flore O, Rafii S, Ely S, O'Leary J, Hyjek E, Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 1998;394:588-92.
63. Panyutich EA, Said JW, Miles SA. Infection of primary dermal microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus. AIDS 1998;12:467-72.
64. Schulze-Osthoff K, Goerdt S, Sorg C. Expression of basic fibroblast growth factor (bFGF) in Kaposi's sarcoma: an immunohistologic study. J Invest Dermatol 1990;95:238-40.
65. Oxholm A, Oxholm P, Permin H, Bendtzen K. Epidermal tumour necrosis factor alpha and interleukin 6-like activities in AIDS-related Kaposi's sarcoma: an immunohistological study. APMIS 1989;97:533-8.
66. Cai J, Gill PS, Masood R, et al. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol 1994;145:74-9.
67. Aboulafavia D, Miles S, Saks S, Mitsuyasu R. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr 1989;2:54-8.
68. Swerlick RA, Garcia GE, Kubota Y, Xu YL, Lawley TJ. Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells. J Invest Dermatol 1991;97:190-6.
69. Swerlick RA, Lee KH, Li LJ, Sepp NT, Caughman SW, Lawley TJ. Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 1992;149:698-705.